JEIO Co., Ltd.

As of June 30, 2026, JEIO Co., Ltd. carries a market capitalization of 144.93B, placing it among publicly traded companies globally. Its enterprise value stands at 141.43B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

JEIO Co., Ltd.'s next confirmed earnings release is scheduled for November 13, 2026.

As of June 30, 2026, JEIO Co., Ltd. has 29.82M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 3.51, and the price-to-book ratio stands at 0.87.

As of June 30, 2026, JEIO Co., Ltd. trades at an EV/EBITDA multiple of 187.90 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.42 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 141.43B versus a market cap of 144.93B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, JEIO Co., Ltd. maintains a current ratio of 4.39, meaning it holds 4.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 16.38, indicating elevated leverage, while an interest coverage ratio of 0.97 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, JEIO Co., Ltd. posted a negative return on equity (ROE) of -3.86, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -3.15, reflecting losses generated across the asset base. The company generates approximately 240.32M in revenue per employee across its workforce of 172.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.51 indicates how many times JEIO Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, JEIO Co., Ltd. recorded an income tax benefit of -261.39M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -6.86B and -6.60B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, JEIO Co., Ltd.'s stock has declined approximately 50.68% over the past 52 weeks. The 50-day moving average sits at 4,768.90, while the 200-day moving average is 6,842.43.

Over the twelve months ended June 30, 2026, JEIO Co., Ltd. generated 41.34B in revenue and converted that into -6.60B in net income, yielding earnings per share of -221.23. EBITDA reached 752.68M, while operating income came in at -7.80B.

As of June 30, 2026, JEIO Co., Ltd. holds 30.92B in cash and equivalents against 27.42B in total debt, resulting in a net debt position of 19.99B. Total book value stands at 167.40B, with working capital of 44.29B providing operational flexibility.

JEIO Co., Ltd. produced 2.31B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -6.15B in capital expenditures, free cash flow totaled -3.84B - equivalent to -128.79 per share.

Over the twelve months ended June 30, 2026, JEIO Co., Ltd. posted a gross margin of -1.52, reflecting its pricing power and cost economics. The operating margin of -18.86 and net profit margin of -15.96 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -2.65: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 1.62, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to JEIO Co., Ltd. shareholders.

As of June 30, 2026, JEIO Co., Ltd. has an Altman Z-Score of 2.74, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.